Imported strongyloidiasis: Epidemiology, presentations, and treatment

Current Infectious Disease Reports

Volumn 14, Issue 3, 2012, Pages 256-262

  Buonfrate, Dora ^a   Angheben, Andrea ^a   Gobbi, Federico ^a   Muñoz, Jose ^b   Requena Mendez, Ana ^b   Gotuzzo, Eduardo ^c   Mena, Maria Alejandra ^c   Bisoffi, Zeno ^a  

^a SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^c INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

Author keywords

Immigrants; Imported; Migration; Strongyloides stercoralis; Travel; Travellers

Indexed keywords

ALBENDAZOLE; IVERMECTIN;

ABDOMINAL PAIN; ARTICLE; CLINICAL FEATURE; COUGHING; DIARRHEA; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; DYSPNEA; EOSINOPHILIA; HUMAN; IMMIGRANT; INCIDENCE; INFECTION RISK; LOEFFLER PNEUMONIA; PREVALENCE; RASH; REFUGEE; RISK ASSESSMENT; RISK FACTOR; SINGLE DRUG DOSE; SKIN PRURITUS; STRONGYLOIDIASIS; TRAVEL; URTICARIA;

EID: 84865627036     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-012-0248-6     Document Type: Article

References (51)

1. Olsen A, van Lieshout L, Marti H, et al. Strongyloidiasis -The most neglected of the neglected tropical diseases? Trans R Soc Trop Med Hyg. 2009;103(10):967-72.
2. World Health Organization: Strongyloidiasis fact sheet. Available at: Http://www.who.int/neglected-diseases/diseases/strongyloidiasis/en/. Accessed December 2011.
3. Prendki V, Fenaux P, Durand R, et al. Strongyloidiasis in man 75 years after initial exposure. Emerg Infect Dis. 2011;17(5):931-2.
4. Boulware DR, Stauffer WM, Hendel-Paterson BR, et al. Maltreatment of Strongyloides infection: Case series and worldwide physicians-in-Training survey. Am J Med 2007;120(6):545 e541-548.
5. Keiser PB, Nutman TB. Strongyloides stercoralis in the Immunocompromised Population. Clin Microbiol Rev. 2004;17(1):208-17. (Pubitemid 38120934)
6. Nuesch R, Zimmerli L, Stockli R, et al. Imported strongyloidosis: A longitudinal analysis of 31 cases. J Travel Med. 2005;12(2):80-4. (Pubitemid 40593474)
7. Baaten GG, Sonder GJ, van Gool T, et al. Travel-related schistosomiasis, strongyloidiasis, filariasis, and toxocariasis: The risk of infection and the diagnostic relevance of blood eosinophilia. BMC Infect Dis. 2011;11:84. A prospective, well-designed study, aimed at investigating the risk of acquiring strongyloidiasis and other parasitosis during travel.
8. Bottieau E, Van Gompel A. Screening the asymptomatic traveler returning from the tropics. Rev Med Suisse. 2009;5(202):1016-21.
9. Sudarshi S, Stumpfle R, Armstrong M, et al. Clinical presentation and diagnostic sensitivity of laboratory tests for Strongyloides stercoralis in travellers compared with immigrants in a nonendemic country. Trop Med Int Health: TM & IH. 2003;8 (8):728-32. (Pubitemid 36960459)
10. Checkley AM, Chiodini PL, Dockrell DH, et al. Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management. J Infect. 2010;60 (1):1-20.
11. Hochberg NS, Moro RN, Sheth AN, et al. High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States. PLoS Negl Trop Dis. 2011;5(4):e1034.
12. Posey DL, Blackburn BG, Weinberg M, et al. High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees. Clin Infect Dis: An official publication of the Infectious Diseases Society of America. 2007;45 (10):1310-5. (Pubitemid 351411906)
13. Caruana SR, Kelly HA, Ngeow JY, et al. Undiagnosed and potentially lethal parasite infections among immigrants and refugees in Australia. J Travel Med. 2006;13(4):233-9. (Pubitemid 44060777)
14. Gualdieri L, Rinaldi L, Petrullo L, et al. Intestinal parasites in immigrants in the city of Naples (southern Italy). Acta Trop. 2011;117(3):196-201.
15. Newberry AM, Williams DN, Stauffer WM, et al. Strongyloides hyperinfection presenting as acute respiratory failure and gramnegative sepsis. Chest. 2005;128(5):3681-4. (Pubitemid 41698712)
16. Mascarello M, Gobbi F, Angheben A, et al. Prevalence of Strongyloides stercoralis infection among HIV-positive immigrants attending two Italian hospitals, from 2000 to 2009. Ann Trop Med Parasitol 2011;In Press.
17. Ouimet MJ, Munoz M, Narasiah L, et al. Current pathologies among asylum seekers in Montreal: Prevalence and associated risk factors. Canadian Journal of Public Health Revue canadienne de sante publique. 2008;99(6):499-504.
18. Gibney KB, Mihrshahi S, Torresi J, et al. The profile of health problems in African immigrants attending an infectious disease unit in Melbourne, Australia. Am J Trop Med Hyg. 2009;80 (5):805-11.
19. Keystone JS. Can one afford not to screen for parasites in high-risk immigrant populations? Clin Infect Dis: An official publication of the Infectious Diseases Society of America. 2007;45(10):1316-8 (Pubitemid 351411907)
20. Fitzpatrick MA, Caicedo JC, Stosor V, et al. Expanded infectious diseases screening program for Hispanic transplant candidates. Clin Infect Dis: An official journal of the Transplantation Society. 2010;12(4):336-41. This paper highlights the importance of expanding the pre-Transplant screening to "neglected" infections particularly relevant in some groups of donors.
21. Gonzalez A, Gallo M, Valls ME, et al. Clinical and epidemiological features of 33 imported Strongyloides stercoralis infections. Trans R Soc Trop Med Hyg. 2010;104(9):613-6.
22. Gonzalez Martinez F, Mellado Pena MJ, Angulo Gonzalez de Lara R, et al. Larva Currens as a differential diagnosis of skin lesions in immigrant children. Anales de pediatria (Barcelona, Spain : 2003) 2010;73(2):102-104.
23. Angheben A,Mistretta M, Gobbo M, et al. Acute strongyloidiasis in Italian tourists returning from Southeast Asia. J Travel Med. 2011;18 (2):138-40. This paper reports features of this rarely described presentation of strongyloidiasis.
24. Marcos LA, Terashima A, Dupont HL, et al. Strongyloides hyperinfection syndrome: An emerging global infectious disease. Trans R Soc Trop Med Hyg. 2008;102(4):314-8.
25. Feely NM, Waghorn DJ, Dexter T, et al. Strongyloides stercoralis hyperinfection: Difficulties in diagnosis and treatment. Anaesthesia. 2010;65(3):298-301.
26. Basile A, Simzar S, Bentow J, et al. Disseminated Strongyloides stercoralis: Hyperinfection during medical immunosuppression. J Am Acad Dermatol. 2010;63(5):896-902.
27. Fusco DN, Downs JA, Satlin MJ, et al. Non-oral treatment with ivermectin for disseminated strongyloidiasis. Am J Trop Med Hyg. 2010;83(4):879-83.
28. Grijsen M, van den Berk G, Hoekstra E, et al. Intestinal strongyloidiasis as a presenting symptom of HTLV-1-Associated adult T-cell leukemia/lymphoma. Endoscopy. 2009;41 Suppl 2: E271-272.
29. Roman-Velez JM, Martinez-Camacho RN, Alayon-Laguer D, et al. An unusual presentation of alveolar hemorrhage. Prim Care Respir J: Journal of the General Practice Airways Group. 2009;18(4):337-9.
30. Rojo-Marcos G, Cuadros-Gonzalez J, Gonzalez-Juarez MJ, et al. Strongyloides stercoralis hyperinfection syndrome in a Colombian patient receiving immunosuppressive treatment. Enferm Infecc Microbiol Clin. 2009;27(7):432-4.
31. Agarwal VK, Khurana HS, Le HX, et al. 30-year-old HIV-positive female with diffuse alveolar hemorrhage. J Intensive Care Med. 2009;24(3):200-4.
32. Balagopal A, Mills L, Shah A, et al. Detection and treatment of Strongyloides hyperinfection syndrome following lung transplantation. Transpl Infect Dis: An official journal of the Transplantation Society. 2009;11(2):149-54.
33. Khasawneh F, Sreedhar R, Chundi V. Strongyloides hyperinfection: An unusual cause of respiratory failure. Ann Intern Med. 2009;150(8):570-1.
34. N'Dri K, Kouame KE, Sahari R, et al. Strongyloides stercoralis hyperinfection syndrome with acute meningoencephalitis associated to HTLV-1 and HTLV-2 virus co-infection. Med Mal Infect. 2008;38(3):162-4.
35. Janssen R, Vlaminckx BJ, Seldenrijk CA, et al. Strongyloides stercoralis hyperinfection mimicking accelerated form of idiopathic pulmonary fibrosis. Lancet Infect Dis. 2008;8(7):456. (Pubitemid 351853098)
36. Miller MA, Church LW, Salgado CD. Strongyloides hyperinfection: A treatment dilemma. Am J Med Sci. 2008;336(4):358-61.
37. Rotolo U, Scarlata F, Giordano S, et al. Nephrotic syndrome and Gram-negative sepsis in a patient with strongyloidiasis: A case report. Le infezioni in medicina: rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive. 2007;15(1):59-62. (Pubitemid 46759327)
38. Foreman EB, Abraham PJ, Garland JL. Not your typical strongyloides infection: A literature review and case study. South Med J. 2006;99 (8):847-52. (Pubitemid 44231623)
39. Gupta S, Jain A, Fanning TV, et al. An unusual cause of alveolar hemorrhage post hematopoietic stem cell transplantation: A case report. BMC Cancer. 2006;6:87.
40. Brugemann J, Kampinga GA, Riezebos-Brilman A, et al. Two donorrelated infections in a heart transplant recipient: One common, the other a tropical surprise. J Heart Lung Transplant: The official publication of the International Society for Heart Transplantation. 2010;29 (12):1433-7.
41. Hamilton KW, Abt PL, Rosenbach MA, et al. Donor-derived Strongyloides stercoralis infections in renal transplant recipients. Transplantation. 2011;91(9):1019-24.
42. Patel G, Arvelakis A, Sauter BV, et al. Strongyloides hyperinfection syndrome after intestinal transplantation. Transpl Infect Dis: An official journal of the Transplantation Society. 2008;10(2):137-41. (Pubitemid 351393083)
43. Rodriguez-Hernandez MJ, Ruiz-Perez-Pipaon M, Canas E, et al. Strongyloides stercoralis hyperinfection transmitted by liver allograft in a transplant recipient. Am J Transplant: Official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2009;9(11):2637-40.
44. van Hattem S, SchuttelaarML. Disseminated strongyloidiasis caused by heart donor-To-host transmission presenting with purpura. Clin Exp Dermatol. 2010;35(4):e149-150.
45. Weiser JA, Scully BE, Bulman WA, et al. Periumbilical parasitic thumbprint purpura: Strongyloides hyperinfection syndrome acquired from a cadaveric renal transplant. Transpl Infect Dis: An official journal of the Transplantation Society. 2011;13(1):58-62.
46. Nontasut P, Muennoo C, Surapol S-N, et al. Prevalence of strongyloides in Northern Thailand and treatment with ivermectin and albendazole. Southeast Asian J Trop Med Public Health. 2005;36(2):442-4. (Pubitemid 40825547)
47. Suputtamongkol Y, Premasathian N, Bhumimuang K, et al. Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis. PLoS Negl Trop Dis. 2011;5(5):e1044. This study confirms that ivermectin is more effective than albendazole for chronic strongyloidiasis.
48. Caumes E, Keystone JS. Acute strongyloidiasis: A rarity. Chronic strongyloidiasis: A time bomb! J Travel Med. 2011;18(2):71-2.
49. Gilbert DN, Moellering RC, Eliopoulos GM, et al. The Sanford guide to antimicrobial therapy. Forty-First Edition 2011;137.
50. Bisoffi Z, Buonfrate D, Angheben A, et al. Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis. PLoS Negl Trop Dis. 2011;5(7):e1254. Thiabendazole and ivermectin for the treatment of chronic strongyloidiasis: No significant difference in efficacy between the two drugs, but better tolerability of ivermectin.
51. Biggs BA, Caruana S, Mihrshahi S, et al. Management of chronic strongyloidiasis in immigrants and refugees: Is serologic testing useful? Am J Trop Med Hyg. 2009;80(5):788-91.